Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simron Singh

Showing results (81-90 of 141) with videos related to

Pageof 15
Sort By:
Endocrine-Related Cancer|May 21, 2021
A pilot study of everolimus and radiation for neuroendocrine liver metastasesSten Myrehaug, David L Chan, Victor Rodriguez-Freixinos, et al.
Canadian Journal of Gastroenterology & Hepatology|July 12, 2014
Surveillance patterns after curative-intent colorectal cancer surgery in OntarioJensen Tan, Jennifer Muir, Natalie Coburn, et al.
Trials|May 2, 2024
Correction: Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NETSimron Singh, Diego Ferone, Jaume Capdevila, et al.
Cancers|February 13, 2025
<sup>68</sup>Ga-DOTATATE PET/CT in the Initial Staging of Well-Differentiated Gastroenteropancreatic and Non-Gastroenteropancreatic Neuroendocrine Tumors: Results of a Prospective RegistryUr Metser, Roshini Kulanthaivelu, Julia Duder, et al.
Cancer|January 10, 2018
Chinese and South Asian ethnicity, immigration status, and clinical cancer outcomes in the Ontario Cancer SystemJames K R Stevenson, Matthew C Cheung, Craig C Earle, et al.
BMC Medical Education|May 13, 2024
Optimizing a mentorship program from the perspective of academic medicine leadership - a qualitative studyMichael Ren, Dorothy Choi, Chloe Chan, et al.
Trials|January 16, 2024
Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NETSimron Singh, Diego Ferone, Jaume Capdevila, et al.
Annals of Surgical Oncology|November 5, 2014
Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert GroupSimron Singh, Chris Dey, Hagen Kennecke, et al.
JAMA Oncology|December 29, 2022
Association of COVID-19 Vaccination With Breakthrough Infections and Complications in Patients With CancerInna Y Gong, Abi Vijenthira, Melanie Powis, et al.
Current Oncology (Toronto, Ont.)|January 9, 2021
SARS-CoV-2 Testing for Asymptomatic Patients with Cancer Prior and during Treatment: A Single Centre ExperienceNicholas Meti, Houman Tahmasebi, Angela Leahey, et al.
Pageof 15

Showing results (81-90 of 141) with videos related to

Sort By:
Pageof 15
Endocrine-Related Cancer|May 21, 2021
A pilot study of everolimus and radiation for neuroendocrine liver metastasesSten Myrehaug, David L Chan, Victor Rodriguez-Freixinos, et al.
Canadian Journal of Gastroenterology & Hepatology|July 12, 2014
Surveillance patterns after curative-intent colorectal cancer surgery in OntarioJensen Tan, Jennifer Muir, Natalie Coburn, et al.
Trials|May 2, 2024
Correction: Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NETSimron Singh, Diego Ferone, Jaume Capdevila, et al.
Cancers|February 13, 2025
<sup>68</sup>Ga-DOTATATE PET/CT in the Initial Staging of Well-Differentiated Gastroenteropancreatic and Non-Gastroenteropancreatic Neuroendocrine Tumors: Results of a Prospective RegistryUr Metser, Roshini Kulanthaivelu, Julia Duder, et al.
Cancer|January 10, 2018
Chinese and South Asian ethnicity, immigration status, and clinical cancer outcomes in the Ontario Cancer SystemJames K R Stevenson, Matthew C Cheung, Craig C Earle, et al.
BMC Medical Education|May 13, 2024
Optimizing a mentorship program from the perspective of academic medicine leadership - a qualitative studyMichael Ren, Dorothy Choi, Chloe Chan, et al.
Trials|January 16, 2024
Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NETSimron Singh, Diego Ferone, Jaume Capdevila, et al.
Annals of Surgical Oncology|November 5, 2014
Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert GroupSimron Singh, Chris Dey, Hagen Kennecke, et al.
JAMA Oncology|December 29, 2022
Association of COVID-19 Vaccination With Breakthrough Infections and Complications in Patients With CancerInna Y Gong, Abi Vijenthira, Melanie Powis, et al.
Current Oncology (Toronto, Ont.)|January 9, 2021
SARS-CoV-2 Testing for Asymptomatic Patients with Cancer Prior and during Treatment: A Single Centre ExperienceNicholas Meti, Houman Tahmasebi, Angela Leahey, et al.
Pageof 15